ID: ALA4161391

Max Phase: Preclinical

Molecular Formula: C59H98N12O13

Molecular Weight: 1183.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O)C1CCCC1

Standard InChI:  InChI=1S/C59H98N12O13/c1-31(2)27-42(63-37(11)73)53(78)62-35(9)51(76)65-43(28-32(3)4)54(79)64-41(19-14-15-25-60)52(77)67-45(30-38-21-23-40(74)24-22-38)55(80)66-44(29-33(5)6)56(81)70-49(39-17-12-13-18-39)58(83)69-48(36(10)72)59(84)71-26-16-20-46(71)57(82)68-47(34(7)8)50(61)75/h21-24,31-36,39,41-49,72,74H,12-20,25-30,60H2,1-11H3,(H2,61,75)(H,62,78)(H,63,73)(H,64,79)(H,65,76)(H,66,80)(H,67,77)(H,68,82)(H,69,83)(H,70,81)/t35-,36+,41-,42-,43-,44-,45-,46-,47-,48-,49-/m0/s1

Standard InChI Key:  PCYVRFDTEIZRCS-ROMUQHLUSA-N

Associated Targets(Human)

TERF2 Tchem Telomeric repeat-binding factor 2 (63 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1183.50Molecular Weight (Monoisotopic): 1182.7376AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S..  (2018)  Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction.,  (5): [PMID:29795768] [10.1021/acsmedchemlett.8b00152]

Source